In addition, we assessed the stemness of glioma cells by measuring a panel of stem cell marker genes using western blotting analysis and observed significantly reduced expression levels of CD133, Nestin, Nanog, and SOX-2 after curcumol treatment (Figure 2D). The gene discussed is SOX2; the disease is central nervous system cancer.